Sujal Shah
About Sujal Shah
Sujal Shah Current Title and Role
Sujal Shah is currently serving as the President and Chief Executive Officer. His leadership role involves overseeing the strategic direction and operations of the company. He brings extensive experience in financial and executive management to his role.
Sujal Shah Board Membership
Sujal Shah serves on the Board of Tvardi Therapeutics. His involvement in the board reflects his depth of experience in the healthcare sector and strategic financial planning.
Sujal Shah Tenure at CymaBay Therapeutics
From December 2013 to March 2017, Sujal Shah served as the Chief Financial Officer at CymaBay Therapeutics. In this capacity, he was responsible for the company's financial strategy, planning, and analysis.
Sujal Shah Career at Citigroup Inc.
Sujal Shah worked as Director of Health Care Investment Banking at Citigroup Inc. from 2010 to 2012. His role involved managing substantial investments and providing financial advisory services within the healthcare sector.
Sujal Shah Experience at Credit-Suisse
Sujal Shah was employed with Credit-Suisse from 2004 to 2010, where he last served as Vice President in the Health Care Investment Banking Group. His responsibilities included advising on mergers and acquisitions, capital raising, and strategic financial planning for healthcare companies.
Sujal Shah Education and Degrees
Sujal Shah earned his MBA from Carnegie Mellon University Tepper School of Business. He also holds M.S. and B.S. degrees in Biomedical Engineering from Northwestern University. His educational background provides a strong foundation in both business and engineering disciplines.